Metastatic breast cancer, version 1.2012: featured updates to the NCCN guidelines.

Carlson RW, Allred DC, Anderson BO, Burstein HJ, Edge SB, Farrar WB, Forero A, Giordano SH, Goldstein LJ, Gradishar WJ, Hayes DF, Hudis CA, Isakoff SJ, Ljung BM, Mankoff DA, Marcom PK, Mayer IA, McCormick B, Pierce LJ, Reed EC, Smith ML, Soliman H, Somlo G, Theriault RL, Ward JH, Wolff AC, Zellars R, Kumar R, Shead DA, National Comprehensive Cancer Network
J Natl Compr Canc Netw. 2012 10 (7): 821-9

PMID: 22773798 · PMCID: PMC3753191 · DOI:10.6004/jnccn.2012.0086

MeSH Terms (8)

Antineoplastic Agents, Hormonal Biomarkers, Tumor Breast Neoplasms Female Humans Neoplasm Metastasis Protein Kinase Inhibitors TOR Serine-Threonine Kinases

Connections (1)

This publication is referenced by other Labnodes entities: